VSV VECTOR-ENCODED HCV ENVELOPE PROTEINS E1/E2 AS VACCINES AGAINST HEPATITIS C VIRUS

SELF-CLEAVING POLYPROTEINS AND USES THEREOF

METHOD OF PURIFYING WHOLE VIRUS PARTICLES

Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles

USE OF RAPAMYCIN AS VACCINE ADJUVANT AND PREPARATION METHOD THEREFOR

Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions

HEPATITIS C VIRUS VACCINE COMPOSITION

ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS E1E2 COMPLEX, COMPOSITIONS OF HCV PARTICLES, AND PHARMACEUTICAL COMPOSITIONS

Fusion proteins and use thereof for preparing hepatitis C vaccines

Replication-proficient dsRNA capsids and uses thereof

Recombinant human hepatitis C virus-like particle and method for producing the same

Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions

Viral deconstruction through capsid assembly in vitro

Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions

Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins

Chimeric GB virus B (GBV-B)

Hepatitis c viral-like particle purification